## XPEV: XPeng Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -9.0% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($17.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 5 |

**Top Holders:**
- Alibaba Group Holdin: 4.3% (0.0%)
- TMT General Partner : 3.3% (-0.4%)
- Primecap Management : 1.8% (-3.7%)
- UBS Group AG: 1.3% (+23.8%)
- Marshall Wace LLP: 0.7% (+244.3%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.36 indicates undervaluation relative to growth. Revenue growth strong at 42% YoY. Institutional flow bullish (3 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.2B |
| Beta | 1.05 |
| 52W Range | $11.14 - $28.23 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.36 |
| Forward P/E | 7.5 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from -6.3% to -9.0% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 12.0pp (needs >3.0% for momentum thesis). Underperforming sector by 8.7pp, stock-specific weakness. Below SMA200 (0.95x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -8.99% (CS: 1) | Weak |
| RSI_14 | 39.2 | Neutral |
| MACD Histogram | -0.36 | Bearish |
| vs SMA20 | 0.861x | Below |
| vs SMA50 | 0.869x | Below |
| vs SMA200 | 0.951x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $19.66
- **Stop Loss:** $17.08 (13.1% risk)
- **Target:** $22.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 387
- **Position Value:** $7,608.42
- **Portfolio %:** 7.61%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-03-17 (Est: $0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.16 | +65.8% |
| 2025Q2 | $-1.06 | $-0.41 | +61.4% |
| 2025Q1 | $-1.51 | $-0.45 | +70.2% |
| 2024Q4 | $-1.45 | $-1.47 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*